Search Results - "Bewick, David"

Refine Results
  1. 1

    Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis by Bainey, Kevin R, Marquis-Gravel, Guillaume, MacDonald, Blair J, Bewick, David, Yan, Andrew, Turgeon, Ricky D

    Published in PloS one (01-09-2023)
    “…Introduction Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) and stent…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines by Macle, Laurent, MD, Cairns, John A., MD, Andrade, Jason G., MD, Mitchell, L. Brent, MD, Nattel, Stanley, MD, Verma, Atul, MD

    Published in Canadian journal of cardiology (01-10-2015)
    “…Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Program has generated a comprehensive series of documents regarding the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    CARDIOVASCULAR CO-MORBIDITIES AND FIVE YEAR SURVIVAL IN A LARGE CONTEMPORARY OUTPATIENT COHORT OF PATIENTS WITH CHRONIC HEART FAILURE by Arnold, J Malcolm O, Ignaszewski, Andrew, Kaan, Annemarie, Howlett, Jonathan, LeBlanc, Marie, Liu, Peter, Haddad, Haissam, Bewick, David, Ashton, Thomas, Marchiori, Gordon

    “…Dyslipidemia 0.94 (0.88, 1.00) [NS]; Systemic hypertension 1.09 (1.02, 1.16)[*]; Valve disease 1.31 (1.21, 1.42)[[dagger]]; Coronary artery disease 1.37 (1.28,…”
    Get full text
    Journal Article